Sodium hydrogen exchanger inhibitory activity of benzotriazole derivatives

Eur J Med Chem. 2017 Jan 27:126:183-189. doi: 10.1016/j.ejmech.2016.10.005. Epub 2016 Oct 5.

Abstract

Series of benzotriazole derivatives were synthesized and evaluated for their Sodium hydrogen exchanger-1 inhibitory potential. All compounds inhibit Sodium hydrogen exchanger-1 in the in-vitro platelet swelling assay. This is perhaps the first report of NHE-1 inhibitory activity of benzotriazole. The 1-alkyl benzotriazole derivatives were found to be more active than the 2-alkyl isomers. The activity increases with increase in chain length of alkyl moiety. Potency increased from that of benzotriazole (IC50 = 192.68 μM) to heptyl derivative (compound 13; IC50 = 59.23 μM). Introduction of electronegative oxygen atom further increased potency as shown by the benzoyl (compound 16, IC50 = 51.57 μM) and sulfonyl groups (compound 17, IC50 = 50.89 μM; compound 18, IC50 = 49.95 μM).

Keywords: Amiloride; Benzotriazole; Platelet swelling assay; Sodium hydrogen exchanger.

MeSH terms

  • Molecular Docking Simulation
  • Protein Conformation
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors*
  • Sodium-Hydrogen Exchangers / chemistry
  • Sodium-Hydrogen Exchangers / metabolism
  • Structure-Activity Relationship
  • Triazoles / chemical synthesis
  • Triazoles / chemistry*
  • Triazoles / metabolism
  • Triazoles / pharmacology*

Substances

  • Sodium-Hydrogen Exchangers
  • Triazoles
  • benzotriazole